SVRA Savara | $4.17 -6.9% | 5/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $9.50 -> $11.00 | Low | View details for Oppenheimer rating of Savara (NASDAQ:SVRA) on 5/21/2024 |
ALLO Allogene Therapeutics | $2.84 +9.7% | 5/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $13.00 | Low | View details for Oppenheimer rating of Allogene Therapeutics (NASDAQ:ALLO) on 5/21/2024 |
ATXS Astria Therapeutics | $9.59 +0.5% | 5/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $25.00 | Low | View details for Oppenheimer rating of Astria Therapeutics (NASDAQ:ATXS) on 5/21/2024 |
WIX Wix.com | $167.51 -0.3% | 5/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $160.00 -> $200.00 | Low | View details for Oppenheimer rating of Wix.com (NASDAQ:WIX) on 5/21/2024 |
SACH Sachem Capital | $3.21 +0.3% | 5/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $5.00 -> $4.50 | N/A | View details for Oppenheimer rating of Sachem Capital (NYSEAMERICAN:SACH) on 5/20/2024 |
NVDA NVIDIA | $947.80 +2.5% | 5/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $1,100.00 -> $1,100.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 5/17/2024 |
|
CFLT Confluent | $31.81 -0.7% | 5/17/2024 | Initiated by | Oppenheimer | - | Outperform | $37.00 | Low | View details for Oppenheimer rating of Confluent (NASDAQ:CFLT) on 5/17/2024 |
CAPR Capricor Therapeutics | $6.30 +1.6% | 5/17/2024 | Initiated by | Oppenheimer | - | Outperform | $14.00 | Low | View details for Oppenheimer rating of Capricor Therapeutics (NASDAQ:CAPR) on 5/17/2024 |
DE Deere & Company | $391.00 -0.1% | 5/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $456.00 -> $456.00 | Low | View details for Oppenheimer rating of Deere & Company (NYSE:DE) on 5/16/2024 |
HASI Hannon Armstrong Sustainable Infrastructure Capital | $31.75 -0.4% | 5/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $48.00 | Low | View details for Oppenheimer rating of Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI) on 5/16/2024 |
CSCO Cisco Systems | $47.12 0.0% | 5/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $58.00 | Low | View details for Oppenheimer rating of Cisco Systems (NASDAQ:CSCO) on 5/16/2024 |
EPIX ESSA Pharma | $6.24 +9.5% | 5/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $17.00 | Low | View details for Oppenheimer rating of ESSA Pharma (NASDAQ:EPIX) on 5/16/2024 |
MNDY monday.com | $229.40 +0.2% | 5/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $250.00 | Low | View details for Oppenheimer rating of monday.com (NASDAQ:MNDY) on 5/16/2024 |
ADI Analog Devices | $216.70 -0.4% | 5/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $215.00 -> $245.00 | Low | View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 5/16/2024 |
PACS PACS Group | $28.55 +1.2% | 5/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $31.00 -> $32.00 | Low | View details for Oppenheimer rating of PACS Group (NYSE:PACS) on 5/15/2024 |
STRO Sutro Biopharma | $4.90 +4.7% | 5/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 5/15/2024 |
VECO Veeco Instruments | $40.64 +1.6% | 5/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $40.00 -> $45.00 | Low | View details for Oppenheimer rating of Veeco Instruments (NASDAQ:VECO) on 5/15/2024 |
VYGR Voyager Therapeutics | $8.45 +0.2% | 5/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $18.00 | Low | View details for Oppenheimer rating of Voyager Therapeutics (NASDAQ:VYGR) on 5/15/2024 |
WDAY Workday | $259.73 +0.1% | 5/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $350.00 -> $320.00 | Low | View details for Oppenheimer rating of Workday (NASDAQ:WDAY) on 5/15/2024 |
LAND Gladstone Land | $13.26 -1.3% | 5/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $16.00 | Low | View details for Oppenheimer rating of Gladstone Land (NASDAQ:LAND) on 5/15/2024 |
JACK Jack in the Box | $54.11 +2.4% | 5/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $98.00 -> $75.00 | Low | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 5/15/2024 |
ALC Alcon | $88.42 +0.4% | 5/15/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $103.00 | N/A | View details for Oppenheimer rating of Alcon (NYSE:ALC) on 5/15/2024 |
AGYS Agilysys | $102.46 +2.5% | 5/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $100.00 | Low | View details for Oppenheimer rating of Agilysys (NASDAQ:AGYS) on 5/14/2024 |
URGN UroGen Pharma | $12.91 -2.3% | 5/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $34.00 -> $32.00 | Low | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 5/14/2024 |
SRPT Sarepta Therapeutics | $130.83 -0.4% | 5/14/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $180.00 | Low | View details for Oppenheimer rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/14/2024 |
FULC Fulcrum Therapeutics | $7.70 +2.0% | 5/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $14.00 | Low | View details for Oppenheimer rating of Fulcrum Therapeutics (NASDAQ:FULC) on 5/14/2024 |
ACHV Achieve Life Sciences | $5.06 +1.2% | 5/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $11.00 | Low | View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/13/2024 |
CTOS Custom Truck One Source | $4.73 -2.1% | 5/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $7.00 | Low | View details for Oppenheimer rating of Custom Truck One Source (NYSE:CTOS) on 5/13/2024 |
MNMD Mind Medicine (MindMed) | $8.02 -1.4% | 5/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $20.00 | Low | View details for Oppenheimer rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 5/13/2024 |
SLNO Soleno Therapeutics | $47.01 +1.8% | 5/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $59.00 | Low | View details for Oppenheimer rating of Soleno Therapeutics (NASDAQ:SLNO) on 5/13/2024 |
TYRA Tyra Biosciences | $18.72 +2.5% | 5/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $28.00 | Low | View details for Oppenheimer rating of Tyra Biosciences (NASDAQ:TYRA) on 5/13/2024 |
VOR Vor Biopharma | $1.74 -3.9% | 5/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $10.00 | Low | View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 5/13/2024 |
CRSP CRISPR Therapeutics | $55.47 -1.3% | 5/10/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $102.00 -> $95.00 | Low | View details for Oppenheimer rating of CRISPR Therapeutics (NASDAQ:CRSP) on 5/10/2024 |
ZURA Zura Bio | $5.99 -1.0% | 5/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $21.00 | Low | View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 5/10/2024 |
SPB Spectrum Brands | $93.74 +1.8% | 5/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $115.00 | Low | View details for Oppenheimer rating of Spectrum Brands (NYSE:SPB) on 5/10/2024 |
EVCM EverCommerce | $10.86 -0.3% | 5/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | Low | View details for Oppenheimer rating of EverCommerce (NASDAQ:EVCM) on 5/10/2024 |
ARRY Array Technologies | $10.74 -2.0% | 5/10/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $20.00 | N/A | View details for Oppenheimer rating of Array Technologies (NASDAQ:ARRY) on 5/10/2024 |
TARS Tarsus Pharmaceuticals | $38.73 +1.3% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $61.00 | Low | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 5/9/2024 |
CYTK Cytokinetics | $60.60 +1.8% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $107.00 -> $106.00 | Low | View details for Oppenheimer rating of Cytokinetics (NASDAQ:CYTK) on 5/9/2024 |
VRDN Viridian Therapeutics | $13.53 +0.6% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $31.00 | Low | View details for Oppenheimer rating of Viridian Therapeutics (NASDAQ:VRDN) on 5/9/2024 |
Does this make you sick? (Ad) The US Dollar Is "Finished"
A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit |
MCRB Seres Therapeutics | $0.95 +0.1% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $5.00 -> $4.00 | Low | View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 5/9/2024 |
BWAY BrainsWay | $5.49 +2.0% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $11.00 | Low | View details for Oppenheimer rating of BrainsWay (NASDAQ:BWAY) on 5/9/2024 |
IAC IAC | $53.39 -3.2% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $75.00 | Low | View details for Oppenheimer rating of IAC (NASDAQ:IAC) on 5/9/2024 |
APP AppLovin | $84.52 -0.1% | 5/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $97.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 5/9/2024 |
CCSI Consensus Cloud Solutions | $20.13 +2.1% | 5/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $20.00 | Low | View details for Oppenheimer rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 5/9/2024 |
CRBP Corbus Pharmaceuticals | $49.00 +0.9% | 5/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $58.00 -> $60.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/8/2024 |
SAR Saratoga Investment | $23.39 -0.1% | 5/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $24.00 -> $23.00 | Low | View details for Oppenheimer rating of Saratoga Investment (NYSE:SAR) on 5/8/2024 |
PTON Peloton Interactive | $3.67 -6.1% | 5/7/2024 | Reiterated by | Oppenheimer | - | Outperform | | Low | View details for Oppenheimer rating of Peloton Interactive (NASDAQ:PTON) on 5/7/2024 |
FRPT Freshpet | $124.84 -1.4% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $135.00 | Low | View details for Oppenheimer rating of Freshpet (NASDAQ:FRPT) on 5/7/2024 |
RXST RxSight | $62.64 +3.3% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $61.00 -> $72.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 5/7/2024 |
ULTA Ulta Beauty | $388.00 +0.4% | 5/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $500.00 -> $475.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 5/7/2024 |
PLRX Pliant Therapeutics | $15.12 -1.0% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $47.00 -> $48.00 | Low | View details for Oppenheimer rating of Pliant Therapeutics (NASDAQ:PLRX) on 5/7/2024 |
CRVS Corvus Pharmaceuticals | $2.28 -0.4% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $8.00 | Low | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 5/7/2024 |
BOWL Bowlero | $11.93 -0.6% | 5/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $15.00 | Low | View details for Oppenheimer rating of Bowlero (NYSE:BOWL) on 5/7/2024 |
ZETA Zeta Global | $18.50 +5.0% | 5/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $18.00 | Low | View details for Oppenheimer rating of Zeta Global (NASDAQ:ZETA) on 5/7/2024 |
IART Integra LifeSciences | $26.98 -2.0% | 5/7/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Integra LifeSciences (NASDAQ:IART) on 5/7/2024 |
WSC WillScot Mobile Mini | $41.55 +2.2% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $53.00 | Low | View details for Oppenheimer rating of WillScot Mobile Mini (NASDAQ:WSC) on 5/6/2024 |
ACAD ACADIA Pharmaceuticals | $15.00 -0.7% | 5/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $19.00 -> $19.00 | Low | View details for Oppenheimer rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/6/2024 |
ALDX Aldeyra Therapeutics | $4.03 +2.0% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $10.00 | Low | View details for Oppenheimer rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 5/6/2024 |
DYN Dyne Therapeutics | $35.38 +27.8% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $47.00 -> $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 5/6/2024 |
RLAY Relay Therapeutics | $6.82 +0.6% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $25.00 | Low | View details for Oppenheimer rating of Relay Therapeutics (NASDAQ:RLAY) on 5/6/2024 |
ENSG The Ensign Group | $119.56 -0.2% | 5/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $130.00 -> $135.00 | Low | View details for Oppenheimer rating of The Ensign Group (NASDAQ:ENSG) on 5/6/2024 |
TRMB Trimble | $57.32 +0.4% | 5/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $72.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 5/6/2024 |
PACS PACS Group | $28.55 +1.2% | 5/6/2024 | Initiated by | Oppenheimer | - | Outperform | $31.00 | Low | View details for Oppenheimer rating of PACS Group (NYSE:PACS) on 5/6/2024 |
AGCO AGCO | $110.07 +0.0% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $154.00 -> $145.00 | Low | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 5/3/2024 |
APTV Aptiv | $81.93 -0.2% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $148.00 -> $145.00 | Low | View details for Oppenheimer rating of Aptiv (NYSE:APTV) on 5/3/2024 |
BWA BorgWarner | $36.87 -0.6% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $39.00 -> $40.00 | Low | View details for Oppenheimer rating of BorgWarner (NYSE:BWA) on 5/3/2024 |
CI The Cigna Group | $333.37 -1.6% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $370.00 -> $400.00 | Low | View details for Oppenheimer rating of The Cigna Group (NYSE:CI) on 5/3/2024 |
NET Cloudflare | $75.30 -0.4% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $122.00 -> $110.00 | Low | View details for Oppenheimer rating of Cloudflare (NYSE:NET) on 5/3/2024 |
COIN Coinbase Global | $225.19 +8.5% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $276.00 -> $282.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 5/3/2024 |
CTVA Corteva | $56.74 +0.5% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $69.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 5/3/2024 |
THG The Hanover Insurance Group | $137.39 -0.1% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $165.00 | Low | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 5/3/2024 |
ITRI Itron | $107.90 -1.6% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $110.00 | Low | View details for Oppenheimer rating of Itron (NASDAQ:ITRI) on 5/3/2024 |
KYMR Kymera Therapeutics | $36.01 +3.0% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $53.00 -> $52.00 | Low | View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 5/3/2024 |
MRNA Moderna | $141.01 +6.1% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $142.00 -> $163.00 | Low | View details for Oppenheimer rating of Moderna (NASDAQ:MRNA) on 5/3/2024 |
SPXC SPX Technologies | $143.81 +2.6% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $134.00 -> $140.00 | Low | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 5/3/2024 |
SPT Sprout Social | $29.00 -8.8% | 5/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $76.00 -> $43.00 | Low | View details for Oppenheimer rating of Sprout Social (NASDAQ:SPT) on 5/3/2024 |
WCC WESCO International | $187.97 +1.6% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $200.00 | Low | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 5/3/2024 |
XYL Xylem | $145.85 +1.8% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $142.00 -> $147.00 | Low | View details for Oppenheimer rating of Xylem (NYSE:XYL) on 5/3/2024 |
ZBH Zimmer Biomet | $119.67 +0.5% | 5/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $155.00 | Low | View details for Oppenheimer rating of Zimmer Biomet (NYSE:ZBH) on 5/3/2024 |
ARCC Ares Capital | $21.33 +0.2% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $21.00 -> $22.00 | Low | View details for Oppenheimer rating of Ares Capital (NASDAQ:ARCC) on 5/2/2024 |
TCPC BlackRock TCP Capital | $10.86 +0.7% | 5/2/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of BlackRock TCP Capital (NASDAQ:TCPC) on 5/2/2024 |
CG The Carlyle Group | $43.37 +0.7% | 5/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $74.00 -> $68.00 | Low | View details for Oppenheimer rating of The Carlyle Group (NASDAQ:CG) on 5/2/2024 |
FSLR First Solar | $196.34 -0.6% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $269.00 -> $271.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 5/2/2024 |
GNRC Generac | $151.30 +4.5% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $145.00 | Low | View details for Oppenheimer rating of Generac (NYSE:GNRC) on 5/2/2024 |
NGVT Ingevity | $51.01 -4.7% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $58.00 | Low | View details for Oppenheimer rating of Ingevity (NYSE:NGVT) on 5/2/2024 |
INTA Intapp | $36.86 -0.2% | 5/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $42.00 | Low | View details for Oppenheimer rating of Intapp (NASDAQ:INTA) on 5/2/2024 |
JCI Johnson Controls International | $71.00 +0.5% | 5/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $71.00 -> $70.00 | Low | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 5/2/2024 |
NBIX Neurocrine Biosciences | $142.94 +0.9% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $216.00 | Low | View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/2/2024 |
RSI Rush Street Interactive | $8.79 +1.3% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $9.00 -> $10.00 | Low | View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 5/2/2024 |
Does this make you sick? (Ad) The US Dollar Is "Finished"
A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit |
UTHR United Therapeutics | $274.67 +0.1% | 5/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $375.00 -> $400.00 | Low | View details for Oppenheimer rating of United Therapeutics (NASDAQ:UTHR) on 5/2/2024 |
FRSH Freshworks | $14.07 -0.5% | 5/2/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Freshworks (NASDAQ:FRSH) on 5/2/2024 |
NXPI NXP Semiconductors | $273.55 0.0% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $295.00 | Low | View details for Oppenheimer rating of NXP Semiconductors (NASDAQ:NXPI) on 5/1/2024 |
RSG Republic Services | $185.99 -1.2% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $202.00 -> $204.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 5/1/2024 |
DAN Dana | $14.07 +0.3% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $18.00 | Low | View details for Oppenheimer rating of Dana (NYSE:DAN) on 5/1/2024 |
DENN Denny's | $7.74 -0.6% | 5/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $11.00 | Low | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 5/1/2024 |
TREE LendingTree | $45.61 -0.2% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $55.00 | Low | View details for Oppenheimer rating of LendingTree (NASDAQ:TREE) on 5/1/2024 |
AMZN Amazon.com | $183.54 -0.6% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $210.00 -> $220.00 | Low | View details for Oppenheimer rating of Amazon.com (NASDAQ:AMZN) on 5/1/2024 |
TMDX TransMedics Group | $138.62 +0.5% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $125.00 | Low | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 5/1/2024 |
LOVE Lovesac | $27.23 -1.2% | 5/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $35.00 | Low | View details for Oppenheimer rating of Lovesac (NASDAQ:LOVE) on 5/1/2024 |
DPZ Domino's Pizza | $516.11 +0.6% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $530.00 -> $580.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 4/30/2024 |
GS The Goldman Sachs Group | $463.03 +0.0% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $479.00 -> $517.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/30/2024 |
JEF Jefferies Financial Group | $47.07 -0.5% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $56.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/30/2024 |
MS Morgan Stanley | $100.09 -0.2% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $101.00 -> $105.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/30/2024 |
BAC Bank of America | $38.82 -1.2% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $46.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/30/2024 |
C Citigroup | $63.16 -1.4% | 4/30/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $87.00 -> $86.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/30/2024 |
CNC Centene | $77.57 -0.6% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $110.00 | Low | View details for Oppenheimer rating of Centene (NYSE:CNC) on 4/29/2024 |
EXPE Expedia Group | $114.47 +0.1% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $175.00 | Low | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 4/29/2024 |
ROP Roper Technologies | $546.37 +0.8% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $650.00 -> $650.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 4/29/2024 |
SFM Sprouts Farmers Market | $79.19 +0.8% | 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Sprouts Farmers Market (NASDAQ:SFM) on 4/29/2024 |
UBER Uber Technologies | $64.44 -0.3% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $90.00 | Low | View details for Oppenheimer rating of Uber Technologies (NYSE:UBER) on 4/29/2024 |
URI United Rentals | $701.07 +2.2% | 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of United Rentals (NYSE:URI) on 4/29/2024 |
WT WisdomTree | $9.52 +0.7% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $11.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 4/29/2024 |
LECO Lincoln Electric | $227.76 +0.3% | 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Lincoln Electric (NASDAQ:LECO) on 4/29/2024 |
BIIB Biogen | $231.58 +0.4% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $270.00 -> $270.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 4/29/2024 |
DASH DoorDash | $113.96 -3.0% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $150.00 | Low | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 4/29/2024 |
ETSY Etsy | $64.13 +0.3% | 4/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $80.00 | Low | View details for Oppenheimer rating of Etsy (NASDAQ:ETSY) on 4/29/2024 |
HCA HCA Healthcare | $325.15 +0.7% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $330.00 -> $345.00 | Low | View details for Oppenheimer rating of HCA Healthcare (NYSE:HCA) on 4/29/2024 |
CART Maplebear | $32.78 -0.4% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $48.00 | Low | View details for Oppenheimer rating of Maplebear (NASDAQ:CART) on 4/29/2024 |
OSIS OSI Systems | $140.57 +0.9% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $157.00 -> $160.00 | Low | View details for Oppenheimer rating of OSI Systems (NASDAQ:OSIS) on 4/29/2024 |
POOL Pool | $368.29 +0.4% | 4/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $436.00 -> $416.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 4/29/2024 |
GOOGL Alphabet | $176.92 +0.5% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $205.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOGL) on 4/26/2024 |
TEAM Atlassian | $179.68 -0.1% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $250.00 | Low | View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 4/26/2024 |
CSL Carlisle Companies | $419.82 +0.5% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $412.00 -> $430.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/26/2024 |
CARR Carrier Global | $66.00 +1.2% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $63.00 -> $64.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/26/2024 |
DOV Dover | $185.18 +0.6% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $187.00 -> $197.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/26/2024 |
RMD ResMed | $218.85 +0.1% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $205.00 -> $200.00 | Low | View details for Oppenheimer rating of ResMed (NYSE:RMD) on 4/26/2024 |
SPGI S&P Global | $437.80 -0.9% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $482.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/26/2024 |
TDOC Teladoc Health | $12.30 -3.4% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $21.00 | Low | View details for Oppenheimer rating of Teladoc Health (NYSE:TDOC) on 4/26/2024 |
TPH Tri Pointe Homes | $39.74 -0.6% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $41.00 -> $46.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 4/26/2024 |
WM Waste Management | $208.52 -0.9% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $221.00 -> $228.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 4/26/2024 |
TYL Tyler Technologies | $493.80 +1.0% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $500.00 | Low | View details for Oppenheimer rating of Tyler Technologies (NYSE:TYL) on 4/26/2024 |
VRT Vertiv | $99.32 +2.6% | 4/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $96.00 -> $98.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/25/2024 |
CMG Chipotle Mexican Grill | $3,177.80 -1.1% | 4/25/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $2,825.00 -> $3,300.00 | Low | View details for Oppenheimer rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024 |
CYH Community Health Systems | $3.61 -0.8% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $4.50 | Low | View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 4/25/2024 |
HUM Humana | $355.17 -0.3% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $415.00 -> $370.00 | Low | View details for Oppenheimer rating of Humana (NYSE:HUM) on 4/25/2024 |
META Meta Platforms | $468.84 -0.7% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $585.00 -> $500.00 | N/A | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/25/2024 |
ENPH Enphase Energy | $112.65 -0.7% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $133.00 -> $134.00 | Low | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 4/24/2024 |
INCY Incyte | $57.19 +0.2% | 4/24/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $92.00 -> $84.00 | Low | View details for Oppenheimer rating of Incyte (NASDAQ:INCY) on 4/24/2024 |
NBIX Neurocrine Biosciences | $142.94 +0.9% | 4/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $200.00 | Low | View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/24/2024 |
Does this make you sick? (Ad) The US Dollar Is "Finished"
A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit |
NEP NextEra Energy Partners | $33.88 -0.1% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of NextEra Energy Partners (NYSE:NEP) on 4/24/2024 |
PNR Pentair | $84.61 +0.8% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $90.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 4/24/2024 |
PHM PulteGroup | $119.42 +0.2% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $138.00 -> $143.00 | Low | View details for Oppenheimer rating of PulteGroup (NYSE:PHM) on 4/24/2024 |
TSLA Tesla | $173.75 -0.7% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/24/2024 |
TXN Texas Instruments | $199.00 -0.1% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024 |
UPS United Parcel Service | $147.59 -1.1% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $153.00 -> $157.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 4/24/2024 |
V Visa | $278.54 -0.6% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $297.00 -> $299.00 | Low | View details for Oppenheimer rating of Visa (NYSE:V) on 4/24/2024 |
MSCI MSCI | $511.01 -0.2% | 4/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/24/2024 |
EA Electronic Arts | $128.30 +0.4% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $150.00 | Low | View details for Oppenheimer rating of Electronic Arts (NASDAQ:EA) on 4/23/2024 |
GANX Gain Therapeutics | $2.51 -4.6% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Gain Therapeutics (NASDAQ:GANX) on 4/23/2024 |
TTWO Take-Two Interactive Software | $150.90 +2.1% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $185.00 | Low | View details for Oppenheimer rating of Take-Two Interactive Software (NASDAQ:TTWO) on 4/23/2024 |
VZ Verizon Communications | $40.11 0.0% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $48.00 | Low | View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/23/2024 |
CHD Church & Dwight | $106.50 +0.1% | 4/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $120.00 | Low | View details for Oppenheimer rating of Church & Dwight (NYSE:CHD) on 4/23/2024 |
ATRC AtriCure | $22.31 -3.6% | 4/23/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $32.00 | Low | View details for Oppenheimer rating of AtriCure (NASDAQ:ATRC) on 4/23/2024 |
TARA Protara Therapeutics | $2.99 -3.2% | 4/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $30.00 | Low | View details for Oppenheimer rating of Protara Therapeutics (NASDAQ:TARA) on 4/22/2024 |
WT WisdomTree | $9.52 +0.7% | 4/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $11.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 4/22/2024 |
KYMR Kymera Therapeutics | $36.01 +3.0% | 4/22/2024 | Initiated by | Oppenheimer | - | Outperform | $53.00 | Low | View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 4/22/2024 |
GILD Gilead Sciences | $67.90 +0.3% | 4/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $105.00 | Low | View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 4/19/2024 |
NFLX Netflix | $640.82 +3.2% | 4/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 4/19/2024 |
SBUX Starbucks | $77.54 -0.4% | 4/19/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Starbucks (NASDAQ:SBUX) on 4/19/2024 |
BIIB Biogen | $231.58 +0.4% | 4/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $290.00 -> $270.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 4/19/2024 |
EFX Equifax | $251.67 +1.2% | 4/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $291.00 -> $272.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/19/2024 |
USB U.S. Bancorp | $40.84 -0.1% | 4/18/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $54.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 4/18/2024 |
XYL Xylem | $145.85 +1.8% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $133.00 -> $142.00 | Low | View details for Oppenheimer rating of Xylem (NYSE:XYL) on 4/18/2024 |
SAGE Sage Therapeutics | $11.18 -4.4% | 4/18/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $25.00 -> $17.00 | Low | View details for Oppenheimer rating of Sage Therapeutics (NASDAQ:SAGE) on 4/18/2024 |
TRNS Transcat | $124.12 +0.8% | 4/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $125.00 | Low | View details for Oppenheimer rating of Transcat (NASDAQ:TRNS) on 4/18/2024 |
AOS A. O. Smith | $85.84 +0.2% | 4/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of A. O. Smith (NYSE:AOS) on 4/18/2024 |
WMS Advanced Drainage Systems | $177.30 +1.8% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $172.00 -> $180.00 | Low | View details for Oppenheimer rating of Advanced Drainage Systems (NYSE:WMS) on 4/18/2024 |
AVNT Avient | $45.61 -1.0% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $49.00 | Low | View details for Oppenheimer rating of Avient (NYSE:AVNT) on 4/18/2024 |
CSL Carlisle Companies | $419.82 +0.5% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $405.00 -> $412.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/18/2024 |
CARR Carrier Global | $66.00 +1.2% | 4/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $63.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/18/2024 |
CAT Caterpillar | $363.25 +0.1% | 4/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Caterpillar (NYSE:CAT) on 4/18/2024 |
DOV Dover | $185.18 +0.6% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $177.00 -> $187.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/18/2024 |
IEX IDEX | $219.86 -1.1% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $252.00 | Low | View details for Oppenheimer rating of IDEX (NYSE:IEX) on 4/18/2024 |
JCI Johnson Controls International | $71.00 +0.5% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $66.00 -> $71.00 | Low | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 4/18/2024 |
SPT Sprout Social | $29.00 -8.8% | 4/18/2024 | Initiated by | Oppenheimer | - | Outperform | $76.00 | Low | View details for Oppenheimer rating of Sprout Social (NASDAQ:SPT) on 4/18/2024 |
ORCL Oracle | $123.86 -0.5% | 4/18/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Oracle (NYSE:ORCL) on 4/18/2024 |
MWA Mueller Water Products | $19.10 -0.6% | 4/18/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Mueller Water Products (NYSE:MWA) on 4/18/2024 |
AMRC Ameresco | $27.94 +2.2% | 4/17/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Ameresco (NYSE:AMRC) on 4/17/2024 |
BLZE Backblaze | $7.10 -0.3% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $13.00 | Low | View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 4/17/2024 |
BAC Bank of America | $38.82 -1.2% | 4/17/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $45.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/17/2024 |
FSLR First Solar | $196.34 -0.6% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $269.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 4/17/2024 |
MS Morgan Stanley | $100.09 -0.2% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $101.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/17/2024 |
PANW Palo Alto Networks | $303.10 -6.4% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $305.00 -> $330.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024 |
QMCO Quantum | $0.55
| 4/17/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Quantum (NASDAQ:QMCO) on 4/17/2024 |
TWLO Twilio | $60.91 -1.9% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $75.00 | Low | View details for Oppenheimer rating of Twilio (NYSE:TWLO) on 4/17/2024 |
VIRX Viracta Therapeutics | $0.81
| 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $13.00 | Low | View details for Oppenheimer rating of Viracta Therapeutics (NASDAQ:VIRX) on 4/17/2024 |
OBDE Blue Owl Capital Co. III | $15.89 +0.2% | 4/17/2024 | Initiated by | Oppenheimer | - | Outperform | $16.00 | Low | View details for Oppenheimer rating of Blue Owl Capital Co. III (NYSE:OBDE) on 4/17/2024 |
SKIL Skillsoft | $8.95 -8.6% | 4/16/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 4/16/2024 |
AGCO AGCO | $110.07 +0.0% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $153.00 -> $154.00 | Low | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 4/16/2024 |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold. |
CTVA Corteva | $56.74 +0.5% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $62.00 -> $67.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 4/16/2024 |
GS The Goldman Sachs Group | $463.03 +0.0% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $446.00 -> $479.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/16/2024 |
AVTX Avalo Therapeutics | $11.10 +15.7% | 4/16/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | | Low | View details for Oppenheimer rating of Avalo Therapeutics (NASDAQ:AVTX) on 4/16/2024 |
C Citigroup | $63.16 -1.4% | 4/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $87.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/15/2024 |
EL Estée Lauder Companies | $131.33 +0.1% | 4/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Estée Lauder Companies (NYSE:EL) on 4/15/2024 |
JPM JPMorgan Chase & Co. | $195.58 -4.5% | 4/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $219.00 -> $217.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 4/15/2024 |
VRTX Vertex Pharmaceuticals | $445.87 +0.1% | 4/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $500.00 | Low | View details for Oppenheimer rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/15/2024 |
VERU Veru | $1.43 +0.7% | 4/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $5.00 | Low | View details for Oppenheimer rating of Veru (NASDAQ:VERU) on 4/15/2024 |
WFC Wells Fargo & Company | $60.69 0.0% | 4/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 4/15/2024 |
ZWS Zurn Elkay Water Solutions | $32.60 +0.2% | 4/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $37.00 | Low | View details for Oppenheimer rating of Zurn Elkay Water Solutions (NYSE:ZWS) on 4/12/2024 |
RVMD Revolution Medicines | $40.03 +1.6% | 4/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $43.00 -> $45.00 | Low | View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 4/12/2024 |
SKYE Skye Bioscience | $12.00 -0.4% | 4/12/2024 | Initiated by | Oppenheimer | - | Outperform | $25.00 | Low | View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024 |
SKYE Skye Bioscience | $12.49 +4.1% | 4/12/2024 | Initiated by | Oppenheimer | - | Outperform | $25.00 | Low | View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024 |
QTTB Q32 Bio | $30.20 -0.5% | 4/11/2024 | Initiated by | Oppenheimer | - | Outperform | $50.00 | Low | View details for Oppenheimer rating of Q32 Bio (NASDAQ:QTTB) on 4/11/2024 |
LVRO Lavoro | $5.68 +1.6% | 4/11/2024 | Initiated by | Oppenheimer | - | Outperform | $11.00 | Low | View details for Oppenheimer rating of Lavoro (NASDAQ:LVRO) on 4/11/2024 |
XPO XPO | $110.52 +0.3% | 4/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $130.00 -> $140.00 | Low | View details for Oppenheimer rating of XPO (NYSE:XPO) on 4/10/2024 |
KMX CarMax | $72.57 -0.3% | 4/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $105.00 | Low | View details for Oppenheimer rating of CarMax (NYSE:KMX) on 4/9/2024 |
CUE Cue Biopharma | $1.86 -0.5% | 4/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Cue Biopharma (NASDAQ:CUE) on 4/9/2024 |
EFX Equifax | $251.67 +1.2% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $273.00 -> $291.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/9/2024 |
IONS Ionis Pharmaceuticals | $38.75 +0.1% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $75.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/9/2024 |
MSCI MSCI | $511.01 -0.2% | 4/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $659.00 -> $648.00 | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/9/2024 |
SEIC SEI Investments | $67.97 -0.5% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $77.00 -> $80.00 | Low | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 4/9/2024 |
TRU TransUnion | $78.85 +1.5% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $81.00 -> $90.00 | Low | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 4/9/2024 |
APP AppLovin | $84.52 -0.1% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $85.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 4/8/2024 |
META Meta Platforms | $468.84 -0.7% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $525.00 -> $585.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/8/2024 |
GOOG Alphabet | $178.46 +0.7% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $172.00 -> $185.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 4/8/2024 |
HCI HCI Group | $102.45 +2.5% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $140.00 | Low | View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 4/5/2024 |
THG The Hanover Insurance Group | $137.39 -0.1% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $150.00 | Low | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 4/5/2024 |
SIGI Selective Insurance Group | $96.81 -1.0% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $120.00 | Low | View details for Oppenheimer rating of Selective Insurance Group (NASDAQ:SIGI) on 4/5/2024 |
LULU Lululemon Athletica | $328.47 +0.4% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $540.00 -> $445.00 | Low | View details for Oppenheimer rating of Lululemon Athletica (NASDAQ:LULU) on 4/5/2024 |
TRV Travelers Companies | $215.60 -1.9% | 4/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Travelers Companies (NYSE:TRV) on 4/5/2024 |
AXP American Express | $242.30 -0.2% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | Low | View details for Oppenheimer rating of American Express (NYSE:AXP) on 4/5/2024 |
ANGO AngioDynamics | $5.81 -3.8% | 4/5/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $12.00 | Low | View details for Oppenheimer rating of AngioDynamics (NASDAQ:ANGO) on 4/5/2024 |
VRT Vertiv | $99.32 +2.6% | 4/5/2024 | Initiated by | Oppenheimer | - | Outperform | $96.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/5/2024 |
GENI Genius Sports | $5.45 -0.9% | 4/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Genius Sports (NYSE:GENI) on 4/4/2024 |
ULTA Ulta Beauty | $388.00 +0.4% | 4/4/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $600.00 -> $500.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 4/4/2024 |
COIN Coinbase Global | $225.19 +8.5% | 4/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $276.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 4/4/2024 |
AYI Acuity Brands | $261.85 +0.9% | 4/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $315.00 | Low | View details for Oppenheimer rating of Acuity Brands (NYSE:AYI) on 4/4/2024 |
BMEA Biomea Fusion | $13.24 +4.9% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $70.00 | Low | View details for Oppenheimer rating of Biomea Fusion (NASDAQ:BMEA) on 4/3/2024 |
CMCSA Comcast | $39.21 -0.2% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $55.00 | Low | View details for Oppenheimer rating of Comcast (NASDAQ:CMCSA) on 4/3/2024 |
STRO Sutro Biopharma | $4.90 +4.7% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 4/3/2024 |
TMUS T-Mobile US | $163.90 -0.1% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $190.00 | Low | View details for Oppenheimer rating of T-Mobile US (NASDAQ:TMUS) on 4/3/2024 |
VZ Verizon Communications | $40.11 0.0% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 | Low | View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/3/2024 |
ALDX Aldeyra Therapeutics | $4.03 +2.0% | 4/3/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/3/2024 |
AIT Applied Industrial Technologies | $201.05 +2.1% | 4/2/2024 | Initiated by | Oppenheimer | - | Outperform | $235.00 | Low | View details for Oppenheimer rating of Applied Industrial Technologies (NYSE:AIT) on 4/2/2024 |
MVST Microvast | $0.41 0.0% | 4/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $4.00 | Low | View details for Oppenheimer rating of Microvast (NASDAQ:MVST) on 4/2/2024 |
MCO Moody's | $412.75 -0.3% | 4/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $411.00 -> $424.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 4/2/2024 |
SPGI S&P Global | $437.80 -0.9% | 4/2/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $480.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/2/2024 |
TSLA Tesla | $173.75 -0.7% | 4/2/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/2/2024 |
JEF Jefferies Financial Group | $47.07 -0.5% | 4/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $52.00 -> $54.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/2/2024 |
ACHV Achieve Life Sciences | $5.06 +1.2% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $18.00 | Low | View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 4/1/2024 |
CALC CalciMedica | $5.36 -1.7% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $14.00 | Low | View details for Oppenheimer rating of CalciMedica (NASDAQ:CALC) on 4/1/2024 |
CTAS Cintas | $697.46 +0.8% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Cintas (NASDAQ:CTAS) on 4/1/2024 |
DRRX DURECT | $1.04 +11.8% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $5.00 | Low | View details for Oppenheimer rating of DURECT (NASDAQ:DRRX) on 4/1/2024 |
KALA KALA BIO | $6.63 +1.2% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 | Low | View details for Oppenheimer rating of KALA BIO (NASDAQ:KALA) on 4/1/2024 |
CATX Perspective Therapeutics | $1.64 +0.6% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $1.20 -> $1.50 | N/A | View details for Oppenheimer rating of Perspective Therapeutics (NYSE:CATX) on 4/1/2024 |
RH RH | $278.80 -0.4% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of RH (NYSE:RH) on 4/1/2024 |
SMTC Semtech | $40.00 -0.5% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Semtech (NASDAQ:SMTC) on 4/1/2024 |
ZURA Zura Bio | $5.99 -1.0% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $16.00 | Low | View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 4/1/2024 |
SG Sweetgreen | $33.57 -0.8% | 4/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $34.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 4/1/2024 |